XML 35 R53.htm IDEA: XBRL DOCUMENT v3.19.3
STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Jan. 01, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance (in shares)     114,500    
Beginning balance $ 7,279.6 $ 5,869.2 $ 6,687.5 $ 4,780.4  
Adoption of new accounting standards         $ 390.8
Issuance of common stock through employee stock plans 86.1 64.7 205.7 199.6  
Shares withheld related to net share settlement of equity awards (7.9) (7.0) (152.9) (115.0)  
Share-based compensation expense related to employee stock plans 88.9 70.1 246.6 190.9  
Repurchase and retirement of common stock (69.5)   (269.5)    
Net income attributable to Intuitive Surgical, Inc. 396.8 292.5 1,021.6 835.4  
Other comprehensive income 1.2 (0.3) 30.6 0.1  
Capital contribution from noncontrolling interest     10.0 8.0  
Less: net loss attributable to noncontrolling interest in joint venture $ 1.9 (0.7) $ (2.5) (1.7)  
Ending balance (in shares) 115,600   115,600    
Ending balance $ 7,777.1 $ 6,288.5 $ 7,777.1 $ 6,288.5  
Common Stock          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance (in shares) 115,200 113,700 114,500 112,300  
Beginning balance $ 0.1 $ 0.1 $ 0.1 $ 0.1  
Issuance of common stock through employee stock plans (in shares) 600 500 2,000 2,200  
Shares withheld related to net share settlement of equity awards 0 0 (300) (300)  
Repurchase and retirement of common stock (in shares) (200)   (600)    
Ending balance (in shares) 115,600 114,200 115,600 114,200  
Ending balance $ 0.1 $ 0.1 $ 0.1 $ 0.1  
Additional Paid-In Capital          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance 5,430.1 4,928.8 5,170.3 4,679.2  
Issuance of common stock through employee stock plans 86.1 64.7 205.7 199.6  
Shares withheld related to net share settlement of equity awards (0.5) (0.4) (7.2) (6.5)  
Share-based compensation expense related to employee stock plans 88.9 70.1 246.6 190.9  
Repurchase and retirement of common stock (3.7)   (14.5)    
Ending balance 5,600.9 5,063.2 5,600.9 5,063.2  
Retained Earnings          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance 1,819.0 948.1 1,521.7 115.0  
Adoption of new accounting standards         392.1
Shares withheld related to net share settlement of equity awards (7.4) (6.6) (145.7) (108.5)  
Repurchase and retirement of common stock (65.8)   (255.0)    
Net income attributable to Intuitive Surgical, Inc. 396.8 292.5 1,021.6 835.4  
Ending balance 2,142.6 1,234.0 2,142.6 1,234.0  
Accumulated Other Comprehensive Income (Loss)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance 16.1 (16.4) (13.3) (15.5)  
Adoption of new accounting standards         (1.3)
Other comprehensive income 1.7 (0.3) 31.1 0.1  
Ending balance 17.8 (16.7) 17.8 (16.7)  
Total Intuitive Surgical, Inc. Stockholders’ Equity          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance 7,265.3 5,860.6 6,678.8 4,778.8  
Adoption of new accounting standards         $ 390.8
Issuance of common stock through employee stock plans 86.1 64.7 205.7 199.6  
Shares withheld related to net share settlement of equity awards (7.9) (7.0) (152.9) (115.0)  
Share-based compensation expense related to employee stock plans 88.9 70.1 246.6 190.9  
Repurchase and retirement of common stock (69.5)   (269.5)    
Net income attributable to Intuitive Surgical, Inc. 396.8 292.5 1,021.6 835.4  
Other comprehensive income 1.7 (0.3) 31.1 0.1  
Ending balance 7,761.4 6,280.6 7,761.4 6,280.6  
Noncontrolling Interest in Joint Venture          
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beginning balance 14.3 8.6 8.7 1.6  
Other comprehensive income (0.5)   (0.5)    
Capital contribution from noncontrolling interest     10.0 8.0  
Less: net loss attributable to noncontrolling interest in joint venture 1.9 (0.7) (2.5) (1.7)  
Ending balance $ 15.7 $ 7.9 $ 15.7 $ 7.9